00719.HK
Shandong Xinhua Pharmaceutical Co., Ltd.
HKSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
HKD 5.55
+2.21%Price chart
Aug 20Aug 25Aug 28Sep 2Sep 7Sep 10Sep 15Sep 18
Key dataSep 18, 2026
OpenHKD 5.57
From 52W high−28.57%
Volume1.25M
Market capHKD 3.87B
P/E (TTM)15.3x
P/S (TTM)0.4x
Div yield3.11%
Key dataSep 18, 2026
Open
HKD 5.57
From 52W high
−28.57%
Volume
1.25M
Market cap
HKD 3.87B
ValuationView details →
P/E (Fwd)
5.2x
EV/EBITDA
9.1x
P/E (TTM)
15.3x
RSI (14)
43.0
MomentumView details →
1D Return
+2.21%
YTD Return
−15.78%
Similar companies
Latest newsMore news →
Shandong Zibo Xinda Pharmaceutical, a wholly owned subsidiary of Shandong Xinhua Pharmaceutical, received a drug registration certificate from China's National Medical Products Administration for 5mg donepezil hydrochloride orally disintegrating tablets.11h agoShandong Xinhua Pharmaceutical received drug registration certificates from China's National Medical Products Administration for its oral concentrated solution of magnesium sulfate, sodium sulfate and potassium sulfate and oral levocarnitine solution.2d agoXinhua Pharmaceutical's wholly-owned subsidiary Shandong Zibo Xinda Pharmaceutical received approval for its azithromycin tablets 0.25g to pass generic drug consistency evaluation, enabling market entry.20d ago